Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Efficacy of ABX196, a new NKT agonist, in prophylactic human vaccination

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Tefit, J. N.
  • Crabe, S.
  • Orlandini, B.
  • Nell, H.
  • Bendelac, A.
  • Deng, S.
  • Savage, P. B.
  • Teyton, Luc
  • Serra, V.

publication date

  • 2014

journal

  • Vaccine  Journal

subject areas

  • Adjuvants, Immunologic
  • Adult
  • Animals
  • Double-Blind Method
  • Galactosylceramides
  • Hepatitis B
  • Hepatitis B Antibodies
  • Hepatitis B Surface Antigens
  • Hepatitis B Vaccines
  • Humans
  • Interferon-gamma
  • Macaca fascicularis
  • Male
  • Mice
  • Molecular Structure
  • Natural Killer T-Cells
scroll to property group menus

Research

keywords

  • ABX196
  • Adjuvant
  • Glycolipid
  • NKT cells
  • alpha-GalCer
scroll to property group menus

Identity

PubMed Central ID

  • PMC4233108

International Standard Serial Number (ISSN)

  • 0264-410X

Digital Object Identifier (DOI)

  • 10.1016/j.vaccine.2014.08.070

PubMed ID

  • 25218293
scroll to property group menus

Additional Document Info

start page

  • 6138

end page

  • 6145

volume

  • 32

issue

  • 46

©2019 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support